Myles McNulty post on X (Twitter)29 May 2024 09:33
Get looking at Quadrise #QED (I have started buying today).
Serious RNS out today, that I don't think has sunken in yet for many. The trial with unnamed partner in Morocco that has been ongoing for several years, has now been moved into a commercial framework agreement.
Turns out the partner is state-owned OCP S.A., the world's largest producer of phosphate. $11bn in revenue in 2022, £1.6bn in profit after tax.
An absolutely huge partner - and to me it reads like a formality that Quadrise's MSAR and bioMSAR will be rolled out across a number of OCP's sites, in time.
'Green' stocks in the UK micro-/small-cap space are enjoying a real rally at the moment (see PHE, AFC, ITM, CWR, etc.) - I sense a big move approaching for QED, with today's news having been the spark that lit the fuse. As you know, QED has a history of pulling off very fast, very steep share price runs!
Placing out the way; and no interims / prelims particularly close.
The only major near-term risk for me is that the planned trial with MSC / Cargill is delayed again - or worse, cancelled.
But the 29 April RNS on the matter reassured of quite the opposite. In fact, when a breakthrough on that project lands (hopefully, imminently!), I think the brakes are really off Quadrise's share price.
A high risk / return play... But of course you know the score!